Literature DB >> 29492958

Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver.

Joana Marquez1, Ines Fernandez-Piñeiro2, Marcos J Araúzo-Bravo3,4, Gereon Poschmann5, Kai Stühler5, Abdel-Majid Khatib6,7, Alejandro Sanchez2,8, Fernando Unda1, Gaskon Ibarretxe1, Irantzu Bernales9, Iker Badiola1.   

Abstract

Phenotypic transformation of liver sinusoidal endothelial cells is one of the most important stages of liver metastasis progression. The miRNA effects on liver sinusoidal endothelial cells during liver metastasis have not yet been studied. Herein, whole genome analysis of miRNA expression in these cells during colorectal liver metastasis revealed repressed expression of microRNA-20a. Importantly, downregulation of miR-20a occurs in parallel with upregulation of its known protein targets. To restore normal miR-20a levels in liver sinusoidal endothelial cells, we developed chondroitin sulfate-sorbitan ester nanoparticles conjugated with miR-20a in a delivery system that specifically targets liver sinusoidal endothelial cells. The restoration of normal mir-20a levels in these cells induced downregulation of the expression of its protein targets, and this also resulted in a reduction of in vitro LSEC migration and a reduction of in vivo activation and tumor-infiltrating capacity and ability of the tumor decreased by ∼80% in a murine liver metastasis model.
© 2018 UICC.

Entities:  

Keywords:  liver metastasis; liver sinusoidal endothelial cells; miRNA; nanomedicine; therapy

Mesh:

Substances:

Year:  2018        PMID: 29492958     DOI: 10.1002/ijc.31343

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  The role of liver sinusoidal endothelial cells in cancer liver metastasis.

Authors:  Ming Yang; Chunye Zhang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 2.  Non-coding RNAs and potential therapeutic targeting in cancer.

Authors:  Shusuke Toden; Timothy J Zumwalt; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-13       Impact factor: 10.680

3.  Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.

Authors:  Bing Chen; Zijing Xia; Ya-Nan Deng; Yanfang Yang; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Open Biol       Date:  2019-01-31       Impact factor: 6.411

Review 4.  Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients.

Authors:  Octav Ginghină; Ariana Hudiță; Cătălin Zaharia; Aristidis Tsatsakis; Yaroslav Mezhuev; Marieta Costache; Bianca Gălățeanu
Journal:  Materials (Basel)       Date:  2021-05-08       Impact factor: 3.623

Review 5.  Roles of exosomes in diagnosis and treatment of colorectal cancer.

Authors:  Yvette Umwali; Cong-Bo Yue; Abakundana Nsenga Ariston Gabriel; Yi Zhang; Xin Zhang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

6.  LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.

Authors:  Junfeng Sun; Jiyi Hu; Guojun Wang; Zhen Yang; Chunlin Zhao; Xiefu Zhang; Jiaxiang Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-05-18

Review 7.  The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver.

Authors:  Alex L Wilkinson; Maria Qurashi; Shishir Shetty
Journal:  Front Physiol       Date:  2020-08-28       Impact factor: 4.566

Review 8.  Nanovectors Design for Theranostic Applications in Colorectal Cancer.

Authors:  Riccardo Rampado; Sara Crotti; Paolo Caliceti; Salvatore Pucciarelli; Marco Agostini
Journal:  J Oncol       Date:  2019-10-01       Impact factor: 4.375

Review 9.  The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Authors:  Erica Lafoz; Maria Ruart; Aina Anton; Anna Oncins; Virginia Hernández-Gea
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

10.  Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers.

Authors:  Zhiyu Wang; Yaning Wei; Guotao Fang; Dan Hong; Lin An; Ting Jiao; Yan Shi; Aimin Zang
Journal:  Drug Des Devel Ther       Date:  2018-09-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.